Design Therapeutics, Inc. (DSGN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings ...
Design Therapeutics (DSGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). CARLSBAD, Calif., March 03, 2025 (GLOBE ...
After hours: March 14 at 4:23:30 PM EDT Loading Chart for DSGN ...
Explore Design Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DSGN.
Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results